Cargando…
A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, and the incidence in the United States (USA) is increasing. Generally curative therapies are only possible for early-stage cancers, thus biomarkers that can be used to detect early-stage cancers are need...
Autores principales: | Wang, Mengjun, Singal, Amit G., Parikh, Neehar, Kono, Yuko, Marrero, Jorge, Mehta, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740205/ https://www.ncbi.nlm.nih.gov/pubmed/36497452 http://dx.doi.org/10.3390/cancers14235970 |
Ejemplares similares
-
Discovery of Core-Fucosylated Glycopeptides as Diagnostic
Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS
por: Tan, Yifei, et al.
Publicado: (2023) -
A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022) -
Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type-1 diabetes
por: Merchant, Michael L., et al.
Publicado: (2013) -
Linkage Specific Fucosylation of Alpha-1-Antitrypsin in Liver Cirrhosis and Cancer Patients: Implications for a Biomarker of Hepatocellular Carcinoma
por: Comunale, Mary Ann, et al.
Publicado: (2010) -
Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies
por: Liang, Jing, et al.
Publicado: (2019)